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1. IntroductIon
Burkholderia mallei is a gram-negative, obligate 
mammalian pathogen which causes glanders primarily in 
solipeds, including horses, donkeys and mules. Horses are 
considered to be the natural reservoir of B. mallei1. Camels, 
goats, rabbits, bears, cats, wolves, and dogs have been proven 
susceptible to glanders. Human glanders is scarcely reported 
and is associated with animal handlers, veterinarians and 
laboratory workers2-4. Humans get infected by contact with 
sick equids, contaminated fomites, tissues or bacterial cultures 
and the transmission is often through small wounds and skin 
abrasions. Inhalation of contaminated aerosols also results in 
infection. Laboratory-acquired infections can also occur during 
mishandling of cultures or samples4. The outcome of untreated 
infections leading to septicemia is uniformly fatal5,6. Glanders 
has been eradicated from most of the Western hemisphere 
countries; however, it is still endemic in Central and South 
America, Asia and the Middle East1. Recent glanders outbreaks 
have been reported from Turkey, United Arab Emirates, Iraq, 
Iran, Pakistan, China, Brazil, Bahrain, and India, thereby 
reflecting the actual area of endemicity7. B. mallei is resistant to 
many antibiotics. Hence, early detection of the agent is critical 
to ensure the administration of appropriate antibiotics8. B. 
mallei organisms are highly infectious as aerosol, and infection 
requires few organisms, offering the potential for intentional 
release as biological threat agent. The bacterium has been 
classified as category B bioterrorism agent by the Centers for 
Disease Control and Prevention, Atlanta.
Because of its potential for weaponisation, rapid and 
definitive detection of B. mallei is critical to ensure the 
administration of appropriate antibiotic therapy. Identification 
of causative agent employing classical microbiological and 
biochemical methods usually consume more than a week9,10. 
Accuracy of commercially available kits (API 20NE and 
RapID NF) for the identification of B. mallei has been reported 
to be 0–60 per cent11, and they may give false positive results. 
B. mallei being deletion clone of B. pseudomallei shares ~ 99.5 
per cent DNA-DNA sequence identity with the later12. Use of 
molecular and biochemical approaches for identification of B. 
mallei and its differentiation from B. pseudomallei has been 
troublesome because of high level of genetic, biochemical, and 
phenotypic similarities between the two species12-15. B. mallei-
specific molecular assays did not exist for discriminating this 
pathogen from B. pseudomallei till year 2006. PCR based 
assays targeting fliP and bimABm genes were reported for 
definitive identification and differentiation of B. mallei from 
B. pseudomallei and other bacteria16-19. Later, bimABm gene 
orthologue was also reported in few strains of B. pseudomallei 
viz., MSHR668, MSHR172, MSHR491, MSHR3320. 
BurkDiff, a RT-PCR assay targeting a unique conserved 
region in B. mallei and B. pseudomallei genomes containing 
a single nucleotide polymorphism (SNP) differentiated the 
two species21. Previously, a quadruplex qPCR for detection 
and differentiation of B. mallei and B. pseudomallei has been 
developed22. Recently, a duplex PCR assay with fluorescent 
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labelled primers was developed for clear distinction between 
B. mallei and B. pseudomallei/B. thailandensis23. The real time 
PCR based assays require sophisticated instruments and costly 
reagents. Development of simple and cost-effective PCR 
assays can be helpful in detection of pathogens in laboratories 
with resource-limited settings.
PCR is a simple, sensitive and rapid assay for detection 
of pathogens, but possibility of false-negative or false positive 
results are the most important limitations of this method. 
False-positive results in PCR assays can be avoided by using 
anti-contamination procedures. False-negative results due to 
PCR failures deny appropriate treatment and containment/
quarantine, which may lead to spread of infectious disease. 
Hence, a detection method should ensure that the negative 
results are truly negative. Inclusion of an internal amplification 
control (IAC) in the same sample reaction and its co-
amplification with the target sequence would generate a control 
signal in absence of PCR failures. The general guidelines for 
PCR testing require inclusion of IAC in PCR reaction mixture 
for indication of PCR failures24,25. In present investigation, we 
describe a PCR based assay with IAC for detection of B. mallei 
from various artificially spiked samples. 
2. MAtErIALs And MEtHods
The work was carried out in high containment facility, 
a biosafety level 3 laboratory at Defence Research and 
Development Establishment, Gwalior, India.
2.1 Bacterial strains and Growth conditions
Various bacterial strains used in this study are listed in 
Table 1. Standard strains of B. mallei and B. pseudomallei were 
obtained from Central Public Health Laboratory, Colindale, 
London, U.K. Clinical isolates of B. cenocepacia were kindly 
provided by Postgraduate Institute of Medical Education 
and Research (PGIMER), Chandigarh. Standard cultures of 
Pseudomonas putida ATCC 49128, P. aeruginosa ATCC 9027 
and P. fluorescens ATCC 13525 were procured from Hi-Media, 
Mumbai. Other bacterial strains used in the study were taken 
from DRDE, culture collection. All the bacterial cultures were 
grown at 37 °C in their respective media, procured from Difco, 
U.S.A and Hi-Media, India. Genomic DNA from the bacterial 
strains was isolated either by boiling method26 or by DNA 
extraction kit (Qiagen, Hilden, Germany). 
2.2 Identification of B. mallei specific dnA 
sequence
About 3000 ORFs of B. mallei NTCC 10229 strain 
were retrieved from Pathema-Burkholderia bioinformatics 
resource centre (http://pathema.jcvi.org/cgi-bin/Burkholderia/
PathemaHomePage.cgi) and BLAST search was performed 
using online BLASTn search offered by the National Centre for 
Biotechnology Information (NCBI) (http://www.ncbi.nlm.nih.
gov/) for identification of B. mallei specific DNA sequence(s). 
On the basis of BLASTn search, a sub-region of ORF 
BMA10229_0375 of B. mallei NCTC 10229 was selected as 
B. mallei specific DNA sequence for PCR based detection. 
BMA10229_0375 ORF is present on Plus (+) strand of 
chromosome II of B. mallei NCTC 10229 between coordinates 
375855 and 376301. This 447-bp ORF is present in B. 
mallei strains and absent in closely related B. pseudomallei 
strains except B. pseudomallei K 96243, where in initial 
217 bases have 95 per cent sequence identity with sequence 
of BMA10229_0375 (from coordinates 375857 to 376071). 
The ORF, however is disrupted by IS element insertion in B. 
pseudomallei K 9624314. A 244 bp DNA sequence between 
coordinates 376072 and 376315 was selected as B. mallei 
specific DNA sequence and Bms primers were used to amplify 
a sequence of 224-bp (coordinates 376092 to 376315). 
2.3 Primer design and IAc
On the basis of BLAST search, a subregion of ORF 
BMA10229_0375 of B. mallei NCTC 10229 was identified as 
B. mallei specific DNA sequence. Two sets of primers, Bms and 
IAC were designed for specific amplification of B. mallei (224 
bp) and pBluescript SK (+) phagemid (449 bp), respectively 
(Table 1). The IAC primers had 5́ overhanging ends, which 
were identical to Bms primers used to amplify B. mallei specific 
DNA sequence, whereas the 3́ ends were complementary to a 
chosen DNA sequence of pBluescript SK (+) phagemid. 
The PCR reaction mixture for generation of IAC DNA 
contained 1 × PCR master mix (MBI Fermentas, Vilnius, 
Lithuania), 1 μM of each of the primers, and 500 pg of 
pBluescript SK (+) phagemid template DNA. The reaction 
procedure consisted of 35 cycles of denaturation at 94 °C 
for 1 min, primer annealing at 60 °C for 30 s and extension 
at 72 °C for 30 s. The DNA was denatured for 4 min in the 
beginning and finally extended for 5 min at 72 °C. PCR 
product was purified using commercially available kit 
(Fermentas). The concentration of IAC DNA was determined 
spectrophotometrically at 260 nm and was stored in Milli-Q 
water at -20 °C. The following equation was used to calculate 
the copy number of the PCR product.
Number of copies of PCR fragment per microlitre = 
weight of PCR fragment (in g μl-1) × (6.023 × 1023)/(660 g 
mol-1 × number of base pairs of PCR fragment).
2.4 Pcr Amplification of B. mallei specific 
sequence 
PCR was carried out in 25 μl reaction containing 1× 
PCR master mix, 1 μmol l-1 of Bms FP and Bms RP primers, 
1000 copies of IAC DNA, and 100 pg of template DNA of 
B. mallei NCTC 10230. Various concentrations of IAC DNA 
were tried before choosing 1000 copies per reaction. PCR was 
taken through 38 cycles in Bio-Rad iCycler (Thermal cycler) 
(Bio-Rad Laboratories, Hercules, CA, USA) at 94 °C for 1 min 
(denaturation), 59 °C for 30 s (annealling) and 72 °C for 30 s 
Primers Primer name Nucleotide sequence (5́ → 3́ )
Bms 
primers
Bms FP GTGATGGACCGCTGTATCG
Bms RP ATTCACTGCAAGCGTCAGG
IAC 
primers
IAC FP GTGATGGACCGCTGTATCGGT 
GCCACCTAAATTGTAAGCG
IAC RP ATTCACTGCAAGCGTCAGGTGA 
CCGCTACACTTGCCAGC
table 1. List of primers and their nucleotide sequence
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(extension). Gradient temperature from 50 °C to 61 °C was 
initially used before finalising 59 °C as annealing temperature. 
The DNA was denatured for 4 min in the beginning and finally 
extended for 5 min at 72 °C. PCR products were analysed in 
1.5 per cent agarose.
2.5 determination of detection Limit, specificity 
and robustness of Pcr Assay
To determine the detection limit of PCR assay, dilutions 
of genomic DNA of B. mallei were prepared. The PCR reaction 
was processed with known amount of genomic DNA (10 ng/
reaction to 0.1 pg/reaction through 1 ng, 100 pg, 10 pg, 1 pg/
reaction) in separate PCR tubes along with 1000 copies of IAC, 
according to the conditions presented earlier.  
The specificity of Bms primers was checked against 
bacterial cultures shown in Table 1, by incorporating 10 ng 
of template DNA of respective bacterium along with all other 
PCR ingredients. Procedure for PCR was essentially same as 
described in the previous section.
Robustness of the PCR assay was determined by using 
suboptimal concentrations of the reagents and IAC template 
(20 per cent lower or 20 per cent higher). The experiments 
were performed at annealing temperatures of 57 °C, 59 °C, and 
61 °C. All other conditions were kept constant as described 
earlier.
2.6 Validation of Pcr Assay with Environmental 
samples Artificially Inoculated with B. mallei
Duplicate samples of tap water and grass were collected 
from our laboratory in sterile containers. Bengal gram was 
collected from local market. Serially 10-fold diluted overnight 
grown B. mallei culture (1 ml) was spiked in 9.0 ml of water, 
2.0 g of Bengal gram (soaked overnight in Milli-Q water), 
or 2.0 g of grass in such a way that different aliquot of each 
sample received B. mallei bacteria from 101 to 106 through 102, 
103, 104, 105 CFU/ml or g. After keeping at room temperature 
for 20 min, 1 volume of double strength glycerol dextrose 
broth and penicillin (200 Units/ml) was added to each sample 
and incubated at 37 °C in an incubator shaker for 24 h. One 
milliliter sample was collected from spiked material after 8 
and 24 h of growth and DNA was extracted in 50 μl of sterile 
Milli-Q water by boiling method, of which 2 μl was used as 
template DNA for detection by PCR assay. The exact number 
of spiked bacteria was determined by plate count method.
3. rEsuLts
3.1 Pcr Assay optimisation
IAC DNA (449-bp) was prepared by PCR and its copy 
number per microlitre was determined. Temperature gradient 
(50 °C to 61 °C) PCR was performed to optimise the annealing 
temperature of Bms primers. The annealing temperature of 
59 °C was finally selected. One thousand copies of IAC were 
found to be optimum for co-amplification in PCR assay with 
10 pg of purified B. mallei NCTC 10230 genomic DNA.
3.2 Analytical sensitivity, specificity and 
robustness of Pcr Assay
For determination of analytical sensitivity of PCR, ten-
fold serially diluted genomic DNA (10 ng/μl to 0.1 pg/μl) of B. 
mallei was prepared and 1 μl of each of dilutions was added to 
separate PCR tubes along with 1000 copies of IAC. The PCR 
assay could detect 10 pg of B. mallei genomic DNA as indicated 
by presence of 224-bp band on agarose gel electrophoresis of 
PCR products (Fig. 1 Different amounts of purified genomic 
DNA of B. mallei NCTC 10230 (10 ng to 0.1 pg/reaction) were 
used. Lane 1: 100 bp ladder; Lane 2: Negative control; Lane 3: 
10 ng DNA; Lane 4: 1 ng DNA; Lane 5 100 pg DNA; Lane 6: 
10 pg DNA; Lane 7: 1 pg DNA; Lane 8: 0.1 pg DNA).
The specificity of PCR assay was tested against the 
listed bacterial strains (Table 2). The assay could detect all B. 
mallei strains as revealed by presence of a 224-bp B. mallei 
specific amplicon. This amplicon of 224-bp was not observed 
in other bacterial strains. IAC of 449-bp was observed in all the 
bacterial strains indicating the successful completion of PCR. 
With the developed PCR assay, B. mallei can be definitively 
identified and differentiated from B. pseudomallei and other 
closely related species (Table 2).
The developed PCR is robust assay, as there was no 
significant loss in the visibility of bands at less (20 per cent) 
or more (20 per cent) concentrations of PCR reagents and IAC 
DNA. Temperature variation of ±2 °C also did not make any 
change in PCR profile.
3.3 Validation of Pcr Assay with Environmental 
samples Artificially Inoculated with B. mallei 
PCR after 8 h pre-enrichment of sample in glycerol 
dextrose broth could detect as low as 7.2 × 103 CFU/ml of 
B. mallei in tap water. Further enrichment of sample for 24 
h reduced the detection limit of PCR to as low as 72 CFU/
ml in tap water. However, when artificially spiked samples of 
Bengal gram and grass were enriched for 8 h, the detection 
limit of PCR was 7.2 × 104 CFU/g of B. mallei. Neither IAC 
(449-bp) nor B. mallei specific amplicon (224-bp) bands could 
be detected on agarose gel electrophoresis of PCR products of 
Bengal gram and grass samples after 24 h of enrichment. 
4. dIscussIon
Rapid, reliable and specific detection of B. mallei is 
essential to start the appropriate antibiotic therapy at an 
early stage of the disease. Detection of B. mallei employing 
standard microbiological and biochemical tests is time 
consuming and sometimes requires more than seven days. 
Figure 1.  representative photograph of Pcr assay with IAc 
(1000 copies/reaction) showing detection limit of the 
assay .
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Various molecular techniques for differentiation of B. mallei 
and B. pseudomallei are labour intensive and require several 
hours to complete12,27. In contrast, standard PCR techniques 
reduce labour and require significantly less time to give 
results. Therefore, PCR, owing to its rapidity and specificity is 
a method of choice for early detection of B. mallei. However, 
development of PCR-based methodologies for detection and 
differentiation of B. mallei from B. pseudomallei have been 
troublesome due to high level of genetic similarities between 
various Burkholderia species12-15. 
In present study, a 244-bp B. mallei specific DNA 
sequence (between coordinates 376072 and 376315 on + strand 
of chromosome II of B. mallei NCTC 10229) was identified by 
screening around 3000 ORFs using BLASTn search. Recent 
BLASTn search revealed the presence of this target sequence in 
all the ten B. mallei strains (viz. 092700E, 2000031063, 23344, 
6, ATCC 23344, BMQ, FMH 23344, NCTC 10229, NCTC 
10247 and SAVP1) whose genomes have been sequenced 
completely and in twelve other strains (viz. GB8, 2002721280, 
JHU, FMH, ATCC 10399, PRL-20, China 7, China 5, A188, 
2000031281, Strain 11 and A 193) of B. mallei with partially 
sequenced genomes. This target sequence was absent in most 
closely related B. pseudomallei strains except one strain viz. B. 
pseudomallei 7894. The 244-bp target sequence exhibited 91 per 
cent sequence identity with its orthologue in B. pseudomallei 
7894 strain. Hence, the PCR assay developed in this study may 
give false positive result with one strain of B. pseudomallei i.e. 
7894, which is a human isolate obtained from Ecuador in 1962 
and does not phylogenetically belong to Asian or Australian 
populations of B. pseudomallei28. Hence, the PCR assay can be 
used for specific detection and differentiation of B. mallei from 
B. pseudomallei in Asia, Australia, and other regions where B. 
pseudomallei strain 7894 is not prevalent. 
PCR assays are usually performed without internal 
amplification controls (IACs). In PCR, positive and negative 
controls generally indicate about the efficacy of the assay, but 
do not confirm the true negative results of a test sample. An 
individual test negative results may either be true-negative or 
false-negative due to the presence of PCR inhibitors within 
the sample29. Therefore, inclusion of IAC in a PCR assay is 
essential for its validation through a multicentre collaborative 
trial and IACs in PCR assays would give further assurance 
of reliable results30. In present PCR based assay for detection 
of B. mallei, we incorporated an IAC of 449-bp for detection 
of PCR failures. Minimum concentration of IAC DNA (1000 
copies) that generated a good visible band, was optimised to 
avoid competition between IAC DNA and target DNA for Bms 
primers particularly at low concentration of target DNA.
The developed PCR assay was found to be specific 
for detection of B. mallei and its differentiation from B. 
pseudomallei. The amplicon of B. mallei specific sequence 
could be detected in all the six strains of B. mallei used in this 
study. Earlier reported PCR based assay and a real time PCR 
based assay for specific detection of B. mallei targeted bimABm 
gene of B. mallei17, 18. However, later on this gene was reported 
in a few other strains of B. pseudomallei confirming the non-
specificity of bimABm gene
20. Moreover, no IAC was included 
in the conventional PCR assays for detection of B. mallei for 
reliability of the results16,23. 
Robustness is also an important criterion for the 
diagnostic PCR. The performance of the present PCR assay 
was not affected even when 20 per cent less or 20 per cent 
more concentration of PCR reagents and IAC DNA was used. 
The assay could withstand an annealing temperature variation 
of ±2 °C, indicating the robustness of this assay.
Validation of the PCR assay was performed by detecting B. 
mallei in artificially inoculated environmental samples. Water, 
Table 2. Bacterial strains used for the evaluation of specificity 
of Bms primers
Bacterial strain 224-bp Bm 
specific 
amplicon
449-bp 
IAc
Burkholderia mallei 
NCTC 10230                                                                         
NCTC 10229                                                                         
NCTC 10245                                                                         
NCTC 10247                                                                         
NCTC 10260                              
NCTC 3709                                                          
+
+
+
+
+
+
+
+
+
+
+
+
Burkholderia pseudomallei
NCTC 4845                                                             
NCTC 10274                                                                         
NCTC 13392                                                           
NCTC 6700                                                             
–
–
–
–
+
+
+
+
Burkholderia cepacia ATCC 25416 – +
Burkholderia cenocepacia 7656                             
DB174BUCE1
– +
Pseudomonas aeruginosa ATCC 9027 – +
Pseudomonas fluorescens ATCC 13525 – +
Pseudomonas putida ATCC 49128   – +
Brucella abortus NCTC 10093                            – +
Brucella melitensis NCTC 10094 – +
Bacillus anthracis  Sterne – +
Bacillus thuringiensis MTCC 4714     – +
Bacillus subtilis MTCC 736                   – +
Bacillus cereus   ATCC 10876                               – +
Vibrio cholerae ATCC 14033                        – +
Staphylococcus aureus DB180STAU66 – +
Enterococcus  faecalis ATCC 29212   – +
Salmonella
typhi DB177SAEN1                                                 
virchow MTCC 1163                            
typhimurium MTCC 1251                       
enteritidis DB179SAEN3
weltevreden MTCC 1169                        
infantis MTCC 1167                            
paratyphi A DB178SAEN2
–
–
–
–
–
–
–
+
+
+
+
+
+
+
Escherichia coli MTCC 730                                           – +
klebsiella pneumoniae MTCC 432                 – +
Serratia liquifaciens MTCC 1620                  – +
Shigella flexneri MTCC 1457                                         – +
Yersinia enterocolitica DB176YEEN1 – +
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Bengal gram and grass were selected for artificial inoculation 
because these matrices play a role in transmission of glanders 
in equines. PCR detected B. mallei in tap water after 8 h and 
24 h of enrichment. The assay could also detect B. mallei from 
Bengal gram and grass after 8 h of enrichment however, PCR 
failure was observed after 24 h enrichment. Absence of IAC 
and B. mallei specific bands in samples from Bengal gram 
and grass after 24 h of enrichment indicated the PCR failure. 
This may be due to accumulation of PCR inhibitors. The PCR 
inhibitors could have accumulated because of mechanical 
shearing of Bengal gram/grass after 24 h enrichment and/or 
because of overgrowth of non-target bacteria. Results of this 
study showed that glycerol dextrose broth (with 200 Units/ml 
of penicillin) lose its selectivity after 8 h of incubation. Loss of 
selectivity after 6 h of enrichment was reported earlier also by 
Merwyn31, et al. 
This investigation describes a B. mallei-specific PCR 
assay with IAC, capable of differentiating this highly infectious 
pathogen from B. pseudomallei and other closely related 
bacterial species. Results of present study suggest that the PCR 
assay can be used for identification/detection of B. mallei from 
environmental samples. 
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